# Yichang Humanwell Oral Solid Dosage Plant – FDA Inspection, Jul 21, 2023

Source: https://www.keypedia.com/records/fda_inspections/yichang-humanwell-oral-solid-dosage-plant/f7f132d2-91d5-46b0-bb0e-77b079bde60d
Source feed: FDA_Inspections

> FDA inspection 1215546 of Yichang Humanwell Oral Solid Dosage Plant, July 21, 2023. Classification: No Action Indicated (NAI). 2 citations under 21 CFR part 211. Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1215546
- Company Name: Yichang Humanwell Oral Solid Dosage Plant
- Inspection Date: 2023-07-21
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 2

## Related Documents

- [FDA Inspection 1095074 - 2019-06-28](https://www.keypedia.com/records/fda_inspections/yichang-humanwell-oral-solid-dosage-plant/e8869ffa-eeb1-4cfc-a810-53fc37918e93)
- FDA Inspection 1063246 - 2018-06-29
- FDA Inspection 1000211 - 2017-01-06

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/kevin-p-regan/b870e1f2-017c-44ab-bc99-1ca99b474a04)
- [Company Rep](https://www.keypedia.com/people/timothy-h-vo/08da7ca5-7f58-42bf-8046-e3a1bf879b48)

Company: https://www.keypedia.com/companies/yichang-humanwell-oral-solid-dosage-plant/5757d69c-083b-427c-8ee0-a2aa0b6b11c4

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
